Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Perleth, M.
Right arrow Articles by Busse, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Perleth, M.
Right arrow Articles by Busse, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Health technology assessment of oral anticoagulation following heart valve replacement

M. Perleth*,1 and R. Busse2

a Federal Association of Regional Health Insurance Funds, Berlin, Germany
b Euoopean Observatory on Health Care Systems (Madrid Hub), Escuela Nacional de Sanidad, Madrid, Spain

* Correspondence: Dr Matthias Perleth, MPH, Federal Association of Regional Health Insurance Funds, Rungestr. 3-6, 10179 Berlin, Germany.

Abstract

Aims The purpose of this report is to define the role that health technology assessment (HTA; a discipline in which both health outcomes and associated economic variables are investigated) can play in determining the effects of various anticoagulation regimens after mechanical heart valve replacement.

Method and results A review of literature, including meta-analyses and primary studies of oral anticoagulation after heart valve replacement, was conducted. The review revealed that a combination of low-dose anticoagulation and antithrombotic therapy is more beneficial than oral anticoagulation or antiplatelet therapy alone. The addition of high-dose antiplatelet therapy appeared to increase risk for haemorrhagic events, which was in constrast to the effect of low-dose antiplatelet therapy alone. However, the results from earlier studies are not always comparable to those of recent ones because of different reporting methods, various follow-up durations, and a tendency to report outcomes globally rather than presenting stratified analyses.

Conclusion HTA is as a tool with which to determine the most cost-effective therapy for each patient group. Various patient populations should be considered (stratified by sex, type and position of valve) within the scope of a comprehensive HTA, as well as therapeutic options. However, any HTA should be viewed critically and in light of the literature on which it is based.

Key Words: Anticoagulation • biomedical • heart valve replacement • meta-analysis • systematic review • technology assessment

References

  1. Banta D, Oortwijn WJ. Health technology assessment and health care in the European Union. Int J Technol Assess Health Care. 2000;16:626–635[CrossRef][Web of Science][Medline]
  2. Banta HD, Luce BR. Health Care Technology and its Assessment. An International Perspective. Oxford, New York, Tokyo: Oxford University Press; 1993.
  3. Banta HD, Behney CJ, Andrulis DP. Assessing the efficacy and safety of medical technologies. Washington: Office of Technology Assessment; 1978.
  4. Henshall C, Oortwijn WJ, Stevens A, Granados A, Banta D. Priority setting for health technology assessment. Theoretical considerations and practical approaches. A paper produced by the Priority Setting Subgroup of the EUR-ASSESS Project. Int J Technol Assess Health Care. 1997;13:144–185[Web of Science][Medline]
  5. Bitzer EM, Busse R, Kohlmann T, Lühmann D, Perleth M. Health technology assessment in the international context: where does Germany stand? For the German Scientific Working Group Technology Assessment for Health care. [in German]Z Ärztl Fortbild Qualitatssich. 1999;93:33–38[Medline]
  6. Perleth M, Busse R. Health technology assessment in Germany: status, challenges, and development. Int J Health Technol Assess Health Care. 2000;16:412–428[CrossRef]
  7. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407–416[Free Full Text]
  8. Bussey HI, Lyons RM. Controversies in antithrombotic therapy for patients with mechanical heart valves. Pharmacotherapy. 1998;18:451–455[Web of Science][Medline]
  9. Bruckenberger E. Heart Report. 1999;:Bruckenberger E. includingHeart Transplantation. 2000;: Hannover
  10. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635–641[Abstract/Free Full Text]
  11. Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a meta-analysis. Am Heart J. 1995;130:547–552[CrossRef][Web of Science][Medline]
  12. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160:191–196[Abstract/Free Full Text]
  13. Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol. 2001;37:569–578[Abstract/Free Full Text]
  14. Pouleur H, Buyse M. Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials. J Thorac Cardiovasc Surg. 1995;110:463–472[Abstract/Free Full Text]
  15. Arom KV, Emery RW, Nicoloff DM, Petersen RJ. Anticoagulant related complications in elderly patients with St. Jude mechanical valve prostheses. J Heart Valve Dis. 1996;5:505–510[Web of Science][Medline]
  16. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJM, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333:11–17[Abstract/Free Full Text]
  17. Debétaz LF, Ruchat P, Hurni M, et al. St. Jude Medical valve prosthesis: an analysis of long-term outcome and prognostic factors. J Thorac Cardiovasc Surg. 1997;113:134–148[Abstract/Free Full Text]
  18. Yamak B, Iscan Z, Mavitas B, et al. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis. J Heart Valve Dis. 1999;8:665–673[Web of Science][Medline]
  19. Montalescot G, Polle V, Collet JP, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation. 2000;101:1083–1086[Abstract/Free Full Text]
  20. Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation. 1996;94:2107–2112[Abstract/Free Full Text]
  21. Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a ran domized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg. 1997;113:910–916[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Perleth, M.
Right arrow Articles by Busse, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Perleth, M.
Right arrow Articles by Busse, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?